Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/155347
Title: Neoadjuvant and Adjuvant Therapy for Non–Small Cell Lung Cancer
Authors: Chuang, Jody C.;Liang, Ying;Wakelee, Heather a.
subject: Medical Science
Year: 2017
Publisher: ASCRS and ESCRS
Abstract: The use of 4 cycles of cisplatin-based adjuvant chemotherapy is now the standard of care for patients with resected stage II and IIIA non–small cell lung cancer. Neoadjuvant chemotherapy lacks the same level of data as adjuvant treatment, but meta-analyses of this approach support its use. Selection of patients who are most likely to benefit from chemotherapy remain elusive. Ongoing adjuvant trials are exploring biomarkers, molecularly targeted agents, postoperative radiation therapy, and immunotherapy.
URI: http://linkinghub.elsevier.com/retrieve/pii/S0886335017300093
http://dl.umsu.ac.ir/handle/Hannan/155347
ISSN: 
volume: Volume 43
issue: Issue 1
month: January
Appears in Collections:Journal of Cataract- refractive surgery 2017

Files in This Item:
File Description SizeFormat 
2017 JCRS Volume 43 Issue 1 January (24).pdf101.89 kBAdobe PDFThumbnail
Download    Request a copy


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.